Heart Diseases : Health & Medical
Have you read about this recently? Many individuals are finding lower cholesterol food to be just as effective, if not more so than cholesterol medication.Let's take a deeper look at this phenomenon.
Are Americans at risk for heart disease is certainly a question that has been making the rounds lately. But if this is true why are American at risk for heart disease?
How feasible is dietary sodium restriction and what impact does it have on BNP levels?
How much time do you spend exercising everyday? Do you spend 30 minutes exercising? How much do you weigh? Are you overweight now? Are you exercising at all?
The "Hollywood Heart Attack," where the character, clutching his chest, slumps to the floor immediately, does sometimes happen. But many heart attacks do not mimic this model. In particular, women's symptoms of heart attack may be very different from men's in both quality and sev
Minimally invasive heart bypass surgery is also known as the minimally invasive direct coronary artery bypass. It is often abbreviated as MIDCAB. As the name suggests, it is a minimally invasive approach to the conventional 'Coronary Artery Bypass Graft' (CABG).
With the greatly modernized way of life today, certain diseases and physiological imparities are taking precedence over others. During any change in our immediate environment, our body is the last to adapt, because it has a complete physiological environment of its own.
Scar size could mean life or death for patients with severe cardiomyopathy, but which gender is impacted the most?
High blood pressure is one of the leading causes of death allover the world. This disease is blamed for millions of fatalities every year. Aside from its deadly attack it is also very silent. This is the reason why HBP can go unnoticed for years and since it gives out no symptoms there is no way of
Learn about problems related to the development of appropriateness criteria and modifications to guide future iterations.
Use of the synthetic selective factor Xa inhibitor, fondaparinux, at a once-daily subcutaneous dose of 2.5 mg significantly reduces the risk of venous thromboembolism in acutely ill hospitalized medical patients.